Gene expression profiling of recipient immune cells induced by 7 × 19 CAR-T cell dosing in a syngeneic mouse model
Yo Muraki, Yuumi Okuzono, Rina Kurisu, Akiko Abiru, Yukimi Sakoda, Koji Tamada, Chihiro Take · 2026
Read Gene expression profiling of recipient immune cells induced by 7 × 19 CAR-T cell dosing in a syngeneic mouse model by Yo Muraki, Yuumi Okuzono, Rina Kurisu, Akiko Abiru, Yukimi Sakoda, Koji Tamada, Chihiro Take (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352813.txt.
Description
Yo Muraki and six colleagues examine how an upgraded cancer cell therapy rallies the patient's own immune system, in this 2026 PLOS ONE mouse study. The therapy engineers T cells with a synthetic receptor plus two helper molecules that summon and grow immune cells. Conventional versions struggle against solid tumours. Four days after treatment of mice bearing such tumours, the team profiled the host immune cells inside them.
Tumours treated with the upgraded cells filled with the host's own killer T cells and macrophages, which conventional therapy did not achieve. Those host cells switched on inflammatory and summoning genes. The engineered cells, it seems, act as recruiters as much as fighters — a mechanism that could matter for human solid-tumour trials.
Catalog record
| CREATOR | Yo Muraki, Yuumi Okuzono, Rina Kurisu, Akiko Abiru, Yukimi Sakoda, Koji Tamada, Chihiro Take |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42007 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |